These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 26517202

  • 1. Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia.
    Citrome L, Du Y, Risinger R, Stankovic S, Claxton A, Zummo J, Bose A, Silverman BL, Ehrich EW.
    Int Clin Psychopharmacol; 2016 Mar; 31(2):69-75. PubMed ID: 26517202
    [Abstract] [Full Text] [Related]

  • 2. Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: post hoc analysis of randomized clinical trial data.
    Robb AS, Carson WH, Nyilas M, Ali M, Forbes RA, Iwamoto T, Assunção-Talbott S, Whitehead R, Pikalov A.
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):33-8. PubMed ID: 20166794
    [Abstract] [Full Text] [Related]

  • 3. A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia.
    Meltzer HY, Risinger R, Nasrallah HA, Du Y, Zummo J, Corey L, Bose A, Stankovic S, Silverman BL, Ehrich EW.
    J Clin Psychiatry; 2015 Aug; 76(8):1085-90. PubMed ID: 26114240
    [Abstract] [Full Text] [Related]

  • 4. Intramuscular aripiprazole in the control of agitation.
    Currier GW, Citrome LL, Zimbroff DL, Oren D, Manos G, McQuade R, Pikalov AA, Crandall DT.
    J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: a post hoc analysis of 4 randomized, placebo-controlled clinical trials.
    Marder SR, West B, Lau GS, Pultz JA, Pikalov A, Marcus RN, Gutierrez-Esteinou R, Crandall DT.
    J Clin Psychiatry; 2007 May; 68(5):662-8. PubMed ID: 17503974
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of aripiprazole lauroxil in schizophrenic patients presenting with severe psychotic symptoms during an acute exacerbation.
    Potkin SG, Risinger R, Du Y, Zummo J, Bose A, Silverman B, Stankovic S, Ehrich E.
    Schizophr Res; 2017 Dec; 190():115-120. PubMed ID: 28342578
    [Abstract] [Full Text] [Related]

  • 12. The effect of cariprazine on hostility associated with schizophrenia: post hoc analyses from 3 randomized controlled trials.
    Citrome L, Durgam S, Lu K, Ferguson P, Laszlovszky I.
    J Clin Psychiatry; 2016 Jan; 77(1):109-15. PubMed ID: 26845266
    [Abstract] [Full Text] [Related]

  • 13. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.
    Kinon BJ, Stauffer VL, Kollack-Walker S, Chen L, Sniadecki J.
    J Clin Psychopharmacol; 2008 Dec; 28(6):601-7. PubMed ID: 19011427
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy of aripiprazole for the treatment of schizophrenia: what dose is required?].
    Charpeaud T, Samalin L, Llorca PM.
    Encephale; 2014 Feb; 40(1):62-73. PubMed ID: 24445245
    [Abstract] [Full Text] [Related]

  • 15. Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores.
    Ismail Z, Peters-Strickland T, Miguelez M, Baker RA, Hertel P, Eramo A, Jin N, Perry P, Sanchez R, McQuade RD, Kane JM.
    J Clin Psychopharmacol; 2017 Jun; 37(3):347-350. PubMed ID: 28383362
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of HP-3070, an Asenapine Transdermal System, on Symptoms of Hostility in Adults With Schizophrenia: A Post Hoc Analysis of a 6-Week Phase 3 Study.
    Citrome L, Komaroff M, Starling B, Byreddy S, Terahara T, Hasebe M.
    J Clin Psychiatry; 2022 Jun 06; 83(4):. PubMed ID: 35687858
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
    Daniel DG, Currier GW, Zimbroff DL, Allen MH, Oren D, Manos G, McQuade R, Pikalov AA, Crandall DT.
    J Psychiatr Pract; 2007 May 06; 13(3):170-7. PubMed ID: 17522560
    [Abstract] [Full Text] [Related]

  • 18. A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia.
    Chengappa KN, Goldstein JM, Greenwood M, John V, Levine J.
    Clin Ther; 2003 Feb 06; 25(2):530-41. PubMed ID: 12749512
    [Abstract] [Full Text] [Related]

  • 19. Intramuscular aripiprazole in the acute management of psychomotor agitation.
    De Filippis S, Cuomo I, Lionetto L, Janiri D, Simmaco M, Caloro M, De Persis S, Piazzi G, Simonetti A, Telesforo CL, Sciarretta A, Caccia F, Gentile G, Kotzalidis GD, Girardi P.
    Pharmacotherapy; 2013 Jun 06; 33(6):603-14. PubMed ID: 23505124
    [Abstract] [Full Text] [Related]

  • 20. The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies.
    Janicak PG, Glick ID, Marder SR, Crandall DT, McQuade RD, Marcus RN, Eudicone JM, Assunção-Talbott S.
    J Clin Psychiatry; 2009 Jan 06; 70(1):25-35. PubMed ID: 19192472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.